![](https://cdn.snapi.dev/images/v1/o/1/press13-1549980.jpg)
News for Celsion Stock (CLSN)
![](https://cdn.snapi.dev/images/v1/o/1/press13-1549980.jpg)
Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/j/8/press9-1545631.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/7/w/conf17-1541137.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/g/u/conf3-1534363.jpg)
![](https://cdn.snapi.dev/images/v1/g/w/press12-1527771.jpg)
Seeking Alpha •
![](https://cdn.snapi.dev/images/v1/m/o/transcript17-1505660.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/h/u/press2-1504612.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/d/8/conf6-1492893.jpg)
![](https://cdn.snapi.dev/images/v1/b/a/press1-1457902.jpg)
![](https://cdn.snapi.dev/images/v1/6/g/press9-1457870.jpg)
![](https://cdn.snapi.dev/images/v1/a/l/press4-1423227.jpg)
Seeking Alpha •
![](https://cdn.snapi.dev/images/v1/f/u/transcript23-1376539.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/h/b/press2-1375384.jpg)
![](https://cdn.snapi.dev/images/v1/c/9/press14-1365358.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/k/w/conf18-1362559.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/z/q/press19-1330294.jpg)
![](https://cdn.snapi.dev/images/v1/b/l/press19-1320598.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/z/d/press2-1316833.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/i/f/press3-1313824.jpg)
![](https://cdn.snapi.dev/images/v1/i/j/analysis-4937349-1280-46-1309517.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/a/f/conf18-1309317.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/k/w/press11-1309329.jpg)
Benzinga •
![](https://cdn.snapi.dev/images/v1/o/l/finance-gce7dd52b7-1920-1308326.jpg)
![](https://cdn.snapi.dev/images/v1/z/g/press15-1303113.jpg)
Seeking Alpha •
![](https://cdn.snapi.dev/images/v1/1/f/transcript6-1301998.jpg)